ABSTRACT
Lower extremity deep vein thrombosis (DVT) is a common clinical concern, with an incidence that increases with advanced age. DVT typically begins below the knee but may extend proximally and result in pulmonary embolism. Pulmonary embolism can occur in 50% to 60% of patients with untreated DVT and can be fatal. Although clinical examination and plasma d-dimer blood evaluation can often predict the presence of DVT, imaging remains critical for the diagnostic confirmation and treatment planning of DVT. Patients with above-the-knee or proximal DVT have a high risk for pulmonary embolism and are recommended to receive anticoagulation therapy. On the other hand, patients with below-the-knee or distal DVT rarely experience pulmonary embolism, and anticoagulation therapy in these patients remains controversial. However, one sixth of patients with distal DVT may experience extension of their thrombus above the knee and therefore are recommended to undergo serial imaging assessment at 1 week to exclude proximal DVT extension if anticoagulation therapy is not initiated. Ultrasound is the preferred imaging method for evaluation of patients with newly suspected lower extremity DVT. Magnetic resonance and CT venography can be especially helpful for the evaluation of suspected DVT in the pelvis and thigh. Contrast x-ray venography, the historic gold standard for DVT assessment, is now less commonly performed and primarily reserved for patients with more complex presentations such as those with suspected recurrent acute DVT.
Subject(s)
Angiography/methods , Practice Guidelines as Topic , Radiology/standards , Venous Thrombosis/diagnosis , Humans , United States , Venous Thrombosis/classificationABSTRACT
PURPOSE: T2-weighted (T2W) magnetic resonance imaging (MRI) has been used for target delineation in cervix cancer brachytherapy. The objective of this study was to examine the feasibility of using diffusion-weighted magnetic resonance imaging (DWI) for target delineation as compared against T2W imaging. MATERIAL AND METHODS: Fifteen cervix cancer patients, implanted with tandem and ovoid applicators, underwent T2W turbo-spin echo imaging and DWI with a maximum diffusion factor of 800 sec/mm(2) on a 1.5-T MR scanner. Apparent diffusion coefficient (ADC) maps were derived from the DWI. The gross tumor volume was manually delineated on the T2W and ADC datasets for each patient. The agreement between T2W- and ADC-delineated volumes was assessed using the Dice similarity coefficient (DSC). An algorithm was developed to compare the edge contrast of the delineated volumes on T2W images and ADC maps by calculating the percentage difference in the intensity values of selected regions of pixels inside versus outside the target contour. RESULTS: ADC-delineated volumes were generally smaller than T2W-delineated volumes, yielding a low DSC of 0.54 ± 0.22. ADC maps were found to display superior definition of the target volume edge relative to T2W images, yielding a statistically significant difference between the mean edge contrast on ADC (12.7 ± 7.7%) versus that on T2W images (4.6 ± 3.2%; p = 0.0010). CONCLUSIONS: These results suggest that incorporating the use of DWI for cervix cancer brachytherapy may yield gross tumor volumes that are different from those based on T2W images alone.
ABSTRACT
PURPOSE: To study the magnetic resonance imaging characteristics of adrenal and extra-adrenal pheochromocytomas in the abdomen and pelvis. METHODS: We retrospectively reviewed 18 cases of pathologically proven cases of pheochromocytomas in the abdomen and pelvis. These patients have undergone magnetic resonance imaging evaluation before surgery. The study population included 10 men and 7 women (age range, 19-68 years; mean, 38 years). A consensus review of the magnetic resonance images was performed by 2 blinded expert observers. A qualitative evaluation was completed, and the tumors were classified by anatomical location, shape, T2 signal, contrast enhancement, and signal dropout on chemical shift pulse sequences. RESULTS: On T2-weighted images, most lesions demonstrated mild to moderate increased signal intensity (SI) (n = 12), 5 lesions demonstrated a markedly increased SI, and only 1 lesion demonstrated an isointense SI on T2-weighted images.Five lesions demonstrated marked postcontrast enhancement. Three lesions demonstrated moderate enhancement, and 5 lesions demonstrated mild postcontrast enhancement.The pattern of enhancement was variable: 4 salt and pepper, 4 homogeneous, 3 heterogeneous, and 2 target with central necrosis and hemorrhage. None of the lesions contained significant amount of intracellular lipid, as no lesions demonstrated greater than 16.5% signal dropout on out-of-phase compared with in-phase pulse sequences.
Subject(s)
Abdominal Neoplasms/pathology , Magnetic Resonance Imaging/methods , Pelvic Neoplasms/pathology , Pheochromocytoma/pathology , Adult , Aged , Contrast Media , Female , Gadolinium DTPA , Humans , Image Enhancement/methods , Male , Middle Aged , Observer Variation , Retrospective Studies , Young AdultABSTRACT
The contrast provided by diffusion-sensitive magnetic resonance offers the promise of improved tumor localization in organ-confined human prostate cancer (PCa). Diffusion tensor imaging (DTI) measurements of PCa were performed in vivo, in patients undergoing radical prostatectomy, and later, ex vivo, in the same patients' prostatectomy specimens. The imaging data were coregistered to histological sections of the prostatectomy specimens, thereby enabling unambiguous characterization of diffusion parameters in cancerous and benign tissues. Increased cellularity, and hence decreased luminal spaces, in peripheral zone PCa led to approximately 40% and 50% apparent diffusion policy (ADC) decrease compared with benign peripheral zone tissues in vivo and ex vivo, respectively. In contrast, no significant diffusion anisotropy differences were observed between the cancerous and noncancerous peripheral zone tissues. However, the dense fibromuscular tissues in prostate, such as stromal tissues in benign prostatic hyperplasia in central gland, exhibited high diffusion anisotropy. A tissue classification method is proposed to combine DTI and T2-weighted image contrasts that may provide improved specificity of PCa detection over T2-weighted imaging alone. PCa identified in volume rendered MR images qualitatively correlates well with histologically determined PCa foci.
Subject(s)
Algorithms , Diffusion Magnetic Resonance Imaging/methods , Image Interpretation, Computer-Assisted/methods , Prostatic Neoplasms/pathology , Aged , Humans , Image Enhancement/methods , Male , Middle Aged , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
Lower-extremity arteriopathy patients can be managed nonsurgically, but there is no standard algorithm for follow-up. The authors present a consensus on appropriate postangioplasty studies in the setting of claudication or a threatened limb. Physical examination with measurements of the ankle-brachial index should be the first step in patients with recurrent symptoms. When there is high clinical suspicion for a threatened limb, the patient should proceed directly to catheter angiography for possible reintervention. However, in the setting of claudication alone, segmental Doppler pressures and pulse volume recordings are the initial test of choice. Magnetic resonance angiography or ultrasound can be used in conjunction to further characterize lesions with more detail. Computed tomographic angiography may also be used to image lower-extremity vasculature but is limited by the presence of large amounts of vascular calcifications. Novel techniques, including dual-energy computed tomographic angiography and noncontrast magnetic resonance angiography, may provide clinicians with alternative approaches in patients with large amounts of vascular calcifications and renal insufficiency, respectively.
Subject(s)
Angioplasty/adverse effects , Intermittent Claudication/etiology , Intermittent Claudication/surgery , Lower Extremity/blood supply , Practice Guidelines as Topic , Angioplasty/standards , Humans , Secondary Prevention , United StatesABSTRACT
OBJECTIVE: To determine the enhancement phase providing the highest contrast-to-noise ratio (CNR) between cholangiocarcinoma and liver or portal vein on dynamic and delayed gadolinium-enhanced magnetic resonance imaging (MRI). SUBJECTS AND METHODS: Precontrast, 3-phase dynamic postcontrast, and delayed postcontrast MRI of the liver was performed in 25 patients with cholangiocarcinoma and correlated with surgical findings, pathology, and other imaging studies. Contrast-to-noise ratios for tumor relative to adjacent liver and portal vein were calculated from signal intensities determined from regions of interest obtained for each phase of enhancement. A subjective assessment of the signal intensity of the periportal tissues relative to the portal vein was made for each set of delayed images. RESULTS: A mass was visible in 24 of 25 patients. Tumor masses were hypointense in 92%, 67%, 75%, and 21%; isointense in 8%, 8%, 17%, and 12%; and hyperintense in 0%, 25%, 8%, and 67% of patients relative to liver on precontrast, arterial, portal venous, and delayed images, respectively. No single phase of gadolinium enhancement demonstrated consistently superior tumor-versus-liver CNR. Delayed imaging demonstrated the highest tumor-versus-liver CNR in 25% of patients and the lowest in 33%. The portal venous phase demonstrated the highest tumor-versus-portal vein CNR in 75% of patients. Delayed postcontrast images demonstrated the lowest tumor-versus-portal vein CNR in 38% of patients. Periportal tissues were isointense to portal vein in all but 1 patient on delayed images. CONCLUSION: No single phase of dynamic and delayed gadolinium-enhanced MRI demonstrates superior CNR between cholangiocarcinoma and normally enhancing liver, although the portal phase provides the best CNR between tumor and portal vein in most cases. Although delayed enhancement is typical of cholangiocarcinoma, delayed imaging does not necessarily offer superior contrast between tumor and liver parenchyma compared with other phases of enhancement. Differentiation between tumor and portal vein and periportal tissues may be difficult on delayed images.
Subject(s)
Bile Duct Neoplasms/diagnosis , Bile Ducts, Intrahepatic/pathology , Cholangiocarcinoma/diagnosis , Gadolinium DTPA , Image Enhancement/methods , Magnetic Resonance Imaging/methods , Adult , Aged , Aged, 80 and over , Contrast Media/administration & dosage , Female , Humans , Imaging, Three-Dimensional , Male , Middle Aged , Observer Variation , Portal Vein/anatomy & histology , Predictive Value of Tests , Respiration , Retrospective StudiesABSTRACT
OBJECTIVE: Gadolinium is administered as a contrast agent in MRI procedures. Two gadolinium-based contrast agents, gadodiamide and gadoversetamide, interfere with colorimetric total serum calcium methods. The purpose of this prospective observational study was to examine the incidence of calcium interference after gadoversetamide procedures, associated clinical outcomes, and costs 20 months after implementation of quality assurance and physician education programs. MATERIALS AND METHODS: Records of patients who received gadoversetamide from June 24, 2006, to October 7, 2006, were reviewed to determine if a routine calcium test had been performed after the injection. Calcium values were repeated with an alternate method that is less susceptible to gadoversetamide interference. If the difference was > or = 2.0 mg/dL or if the initial test value was < or = 7.0 mg/dL, patient charts were reviewed for any related treatment. Costs associated with this algorithm were tracked. RESULTS: The initial calcium test was performed after gadoversetamide in 766 of 3,439 instances. The alternate test was performed in 633 of 766. One hundred twenty-five of 633 (20%) showed a difference in calcium values that was > or = 0.7 mg/dL, with 16 showing differences of > or = 1.6 mg/dL. Chart review for 56 instances revealed that calcium supplements were administered in 22 of 56 around the time of gadoversetamide injection. However, none appeared to be related to the spurious hypocalcemia. The total additional cost (reagent and technologist) for following this algorithm for just over 3 months was $6,807. CONCLUSION: Approximately 20% of patients receiving gadoversetamide exhibited spurious hypocalcemia. No patients were identified who received inappropriate calcium because of this interference. This may be attributable to the quality assurance and physician education programs.
Subject(s)
Calcium/blood , Contrast Media/pharmacology , Health Care Costs , Hypocalcemia/diagnosis , Hypocalcemia/economics , Organometallic Compounds/pharmacology , Blood Chemical Analysis , Colorimetry , False Positive Reactions , Female , Humans , Hypocalcemia/therapy , Magnetic Resonance Imaging , Male , Prospective Studies , Retrospective StudiesABSTRACT
OBJECTIVES: The results of treatment for subclavian vein effort thrombosis were assessed in a series of competitive athletes. METHODS: A retrospective review was conducted of high-performance athletes who underwent multidisciplinary management for venous thoracic outlet syndrome in a specialized referral center. The overall time required to return to athletic activity was assessed with respect to the timing and methods of diagnosis, initial treatment, operative management, and postoperative care. RESULTS: Between January 1997 and January 2007, 32 competitive athletes (29 male and 3 female) were treated for venous thoracic outlet syndrome, of which 31% were in high school, 47% were in college, and 22% were professional. The median age was 20.3 years (range, 16-26 years). Venous duplex ultrasound examination in 21 patients had a diagnostic sensitivity of 71%, and the mean interval between symptoms and definitive venographic diagnosis was 20.2 +/- 5.6 days (range, 1-120 days). Catheter-directed subclavian vein thrombolysis was performed in 26 (81%), with balloon angioplasty in 12 and stent placement in one. Paraclavicular thoracic outlet decompression was performed with circumferential external venolysis alone (56%) or direct axillary-subclavian vein reconstruction (44%), using saphenous vein panel graft bypass (n = 8), reversed saphenous vein graft bypass (n = 3), and saphenous vein patch angioplasty (n = 3). In 19 patients (59%), simultaneous creation of a temporary (12 weeks) adjunctive radiocephalic arteriovenous fistula was done. The mean hospital stay was 5.2 +/- 0.4 days (range, 2-11 days). Seven patients required secondary procedures. Anticoagulation was maintained for 12 weeks. All 32 patients resumed unrestricted use of the upper extremity, with a median interval of 3.5 months between operation and the return to participation in competitive athletics (range, 2-10 months). The overall duration of management from symptoms to full athletic activity was significantly correlated with the time interval from venographic diagnosis to operation (r = 0.820, P < .001) and was longer in patients with persistent symptoms (P < .05) or rethrombosis before referral (P < .01). CONCLUSIONS: Successful outcomes were achieved for the management of effort thrombosis in a series of 32 competitive athletes using a multidisciplinary approach based on (1) early diagnostic venography, thrombolysis, and tertiary referral; (2) paraclavicular thoracic outlet decompression with external venolysis and frequent use of subclavian vein reconstruction; and (3) temporary postoperative anticoagulation, with or without an adjunctive arteriovenous fistula. Optimal outcomes for venous thoracic outlet syndrome depend on early recognition by treating physicians and prompt referral for comprehensive surgical management.
Subject(s)
Sports , Subclavian Vein , Thoracic Outlet Syndrome/surgery , Venous Thrombosis/surgery , Adolescent , Adult , Anticoagulants/therapeutic use , Female , Humans , Length of Stay , Male , Patient Care Team , Phlebography , Subclavian Vein/surgery , Thoracic Outlet Syndrome/diagnosis , Thoracic Outlet Syndrome/rehabilitation , Thoracic Outlet Syndrome/therapy , Thrombolytic Therapy , Treatment Outcome , Vascular Surgical Procedures/methods , Venous Thrombosis/diagnosis , Venous Thrombosis/rehabilitation , Venous Thrombosis/therapyABSTRACT
Primary retroperitoneal masses are a rare but diverse group of benign and malignant processes. Magnetic resonance (MR) imaging is playing an increasing role in evaluating retroperitoneal soft-tissue masses. Since the MR imaging features of most retroperitoneal soft-tissue masses are nonspecific, prediction of a specific histologic diagnosis remains a challenge for the radiologist. However, there are certain specific MR imaging appearances that are helpful. Dynamic enhancement patterns can reflect the vascularity of masses, differentiating benign from malignant soft-tissue masses. This article pictorially illustrates the MR imaging features of various common and uncommon retroperitoneal masses.
Subject(s)
Magnetic Resonance Imaging , Retroperitoneal Fibrosis/diagnosis , Retroperitoneal Neoplasms/diagnosis , Retroperitoneal Neoplasms/pathology , Histiocytoma, Benign Fibrous/diagnosis , Humans , Lipoma/diagnosis , Liposarcoma/diagnosis , Lymphangioma/diagnosis , Lymphangioma/pathology , Lymphatic Diseases/diagnosis , Lymphatic Metastasis , Nerve Sheath Neoplasms/diagnosis , Paraganglioma/diagnosisABSTRACT
OBJECTIVE: To evaluate the diagnostic yield of MRI performed for characterization of focal hepatic lesions that are interpreted as indeterminate on CT. PATIENTS AND METHODS: In a retrospective investigation, 124 indeterminate focal hepatic lesions in 96 patients were identified on CT examinations over 5 years from 1997 to 2001. All patients had MRI performed for the liver within 6 weeks of their CT examination. CT and MR images were reviewed independently by two separate groups of two radiologists. The value of MRI in characterizing these lesions was assessed. Diagnoses were confirmed based on histology, characteristic imaging features, and clinical follow-up. RESULTS: MRI definitely characterized 73 lesions (58%) that were indeterminate on CT. MRI was accurate in 72/73 of these lesions. MRI could not definitely characterize 51 lesions (42%). Ten lesions were not visualized on MRI, and follow-up imaging confirmed that no lesion was present in eight of these cases (pseudolesions). CONCLUSION: MRI is valuable for the characterization of indeterminate focal hepatic lesions detected on CT.
ABSTRACT
Magnetic resonance (MR) imaging has considerable potential in characterizing pancreatic masses. Certain features can be used by the radiologist to establish a definitive diagnosis for most pancreatic tumors including ductal adenocarcinoma, islet cell tumors, solid and papillary epithelial neoplasms, micro- and macrocystic adenoma, and metastases. Recognition of these tumors on imaging is important since it often changes the treatment approach and may obviate the need for surgery. Recent introduction of 3D gradient recalled echo (GRE) sequence such as volumetric interpolated breath hold examination (VIBE) has dramatically improved MR imaging by providing dynamic enhanced thin-slice images with fat saturation and high signal-to-noise ratio. In this article, special emphasis will be placed on the impact of 3D GRE sequence in the diagnosis of pancreatic neoplasms with pathologic correlation.
Subject(s)
Contrast Media , Imaging, Three-Dimensional , Magnetic Resonance Imaging , Pancreatic Neoplasms/diagnosis , Humans , Magnetic Resonance Imaging/methods , Pancreatic Neoplasms/classification , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/secondaryABSTRACT
Primary sclerosing cholangitis is a progressive cholestatic disease of unknown etiology leading to cirrhosis and liver failure. Several imaging modalities have been used to study this disease, including ultrasonography, computed tomography and hepatobiliary scintigraphy, but accurate diagnosis was found to be best made with endoscopic retrograde cholangiopancreatography or direct cholangiography. However, these 2 methods are invasive and may produce serious complications. Magnetic resonance cholangiopancreatography is a noninvasive imaging technique that has become very useful for diagnosing primary sclerosing cholangitis. Contrast enhanced magnetic resonance imaging provides pertinent information of extraductal abnormalities in addition to biliary ductal changes.
Subject(s)
Cholangiopancreatography, Magnetic Resonance/methods , Cholangitis, Sclerosing/diagnosis , Magnetic Resonance Imaging/methods , Adult , Bile Duct Neoplasms/diagnosis , Bile Ducts, Intrahepatic , Cholangiocarcinoma/diagnosis , Cholangitis, Sclerosing/surgery , Humans , Liver/pathology , Liver Transplantation , Lymphatic Diseases/pathology , Male , Middle AgedABSTRACT
OBJECTIVE: Our objective was to detail peritoneal anatomy, techniques for optimizing peritoneal MRI, and the MRI characteristics of several disease processes that frequently involve the peritoneum. CONCLUSION: Homogeneous fat suppression and dynamic contrast-enhanced imaging, including delayed imaging, are critical technical factors for successful lesion detection and characterization on peritoneal MRI.
Subject(s)
Magnetic Resonance Imaging , Peritoneal Diseases/diagnosis , Peritoneal Neoplasms/diagnosis , Peritoneum/pathology , Adult , Female , Humans , Male , Middle Aged , Peritoneum/anatomy & histologyABSTRACT
Magnetic resonance imaging (MRI) is playing an important role in the clinical evaluation of women presenting with urethral symptoms. Voiding cystourethrography, direct urethrography, and pelvic sonography provide limited information on abnormalities that are in continuity with the urethra. On the other hand, urethra and periurethral tissues can be noninvasively evaluated by high-resolution endocavitary MRI. Because of its multiplanar capability and high tissue contrast, endovaginal MRI is an extremely reliable diagnostic test in the evaluation of urethral abnormalities. In this article, the utility of endovaginal MRI in the detection and characterization of a wide spectrum of urethral pathologic conditions, such as congenital anomalies, diverticula, urethritis, and benign and malignant neoplasms, is discussed.
Subject(s)
Magnetic Resonance Imaging/methods , Urethral Diseases/diagnosis , Female , Humans , Urethra/anatomy & histology , Urethra/pathology , VaginaABSTRACT
Focal hepatic lesions constitute a daily challenge in the clinical setting. However, noninvasive methods can be useful in the detection and characterization of these lesions. The noninvasive diagnosis of liver lesions is usually achieved with contrast material-enhanced computed tomography and magnetic resonance (MR) imaging. Dynamic three-dimensional gradient-recalled-echo MR imaging provides dynamic contrast-enhanced thin-section images with fat saturation and a high signal-to-noise ratio and is excellent for the evaluation of various focal hepatic lesions. A comprehensive MR imaging examination in this setting includes T2-weighted and chemical shift T1-weighted imaging and demonstrates characteristic enhancement patterns that can be helpful in the diagnosis of most of these lesions. These enhancement patterns are seen during particular phases of contrast-enhanced imaging and include arterial phase enhancement, delayed phase enhancement, peripheral washout, ring enhancement, nodule-within-a-nodule enhancement, true central scar, pseudocentral scar, and pseudocapsule. Familiarity with these enhancement patterns can help in the identification of specific focal lesions of the liver.
Subject(s)
Contrast Media , Echo-Planar Imaging , Image Enhancement , Imaging, Three-Dimensional , Liver Diseases/diagnosis , Liver Neoplasms/diagnosis , Aged , Female , Humans , Male , Middle AgedSubject(s)
Choristoma/diagnosis , Magnetic Resonance Imaging , Pancreas , Splenic Diseases/diagnosis , Aged , Female , HumansABSTRACT
The spleen has the same relationship to the circulatory system that the lymph nodes have to the lymphatic system. A wide range of diseases can affect the spleen. Pathologic conditions of the spleen can be classified into the following categories: congenital diseases (accessory spleen, polysplenia, and asplenia); trauma; inflammation (abscess, candidiasis, histoplasmosis, and sarcoidosis); vascular disorders (infarction, diseases affecting the splenic vasculature, and arteriovenous malformation); hematologic disorders (sickle cell disease and extramedullary hematopoiesis); benign tumors (cysts, hemangioma, diffuse hemangiomatosis of the spleen, and hamartoma); malignant tumors (sarcoma, lymphoma, and metastases); and other disease processes that affect the spleen diffusely (portal hypertension, Gaucher disease, and sickle cell disease) or focally (Gamna-Gandy nodules). New magnetic resonance (MR) imaging techniques have increased the role of MR imaging in detection and characterization of splenic diseases. MR imaging is an excellent tool for diagnosis and evaluation of focal lesions and pathologic conditions of the spleen.
Subject(s)
Magnetic Resonance Imaging , Splenic Diseases/diagnosis , Splenic Neoplasms/diagnosis , HumansABSTRACT
PURPOSE: To prospectively determine the safety and efficacy of the gadolinium-based blood pool magnetic resonance (MR) imaging contrast agent gadofosveset in patients known to have or suspected of having peripheral vascular disease. MATERIALS AND METHODS: Ethical committee approval and patient written informed consent were obtained. This study was compliant with the Health Insurance Portability and Accountability Act. Adults known or suspected to have peripheral vascular disease received gadofosveset (0.03 mmol per kilogram of body weight) for MR angiography of the aortoiliac region. Gadofosveset-enhanced MR angiography and unenhanced two-dimensional time-of-flight MR angiography were compared with the reference standard, conventional angiography, for the presence of vascular stenosis. All patients were monitored for adverse events with hematologic analysis, analysis of blood chemistry, urinalysis, and electrocardiographic parameters; these methods were analyzed to determine safety. RESULTS: A total of 274 patients were enrolled at 37 centers. Gadofosveset-enhanced MR angiography showed significant improvement (P < .001) compared with unenhanced MR angiography for each of the readers for diagnosis of clinically significant (> or = 50%) stenosis. Specificity and accuracy were significantly greater for three readers, and sensitivity increased significantly for two readers. For all readers, the area under the receiver operator characteristic curve for both quantitative and qualitative measures of significant disease increased (P < .001) for gadofosveset-enhanced MR angiography versus two-dimensional time-of-flight MR angiography. All readers also expressed more confidence in diagnosis (P < .001) and found fewer images to be uninterpretable (0.5% vs 11.0%). The most common adverse events were as follows: feeling hot, 12 (4.4%) patients; nausea, 10 (3.6%) patients; headache, nine (3.3%) patients; and burning sensation, eight (2.9%) patients. Only four serious adverse events were reported, in three patients, and all events were rated as unlikely related to the drug. No patients were excluded because of adverse events or laboratory abnormalities. There were no clinically important trends in the findings of hematologic analysis, blood chemistry, urinalysis, electrocardiography, or physical examination. CONCLUSION: On the basis of substantial improvements over non-contrast MR angiography in efficacy and a minimal and transient side-effect profile, gadofosveset was found to be safe and effective for MR angiography in patients known or suspected to have peripheral vascular disease.
Subject(s)
Aortic Diseases/diagnosis , Arterial Occlusive Diseases/diagnosis , Iliac Artery , Magnetic Resonance Angiography/methods , Organometallic Compounds , Peripheral Vascular Diseases/complications , Aged , Angiography, Digital Subtraction , Aortic Diseases/etiology , Arterial Occlusive Diseases/etiology , Contrast Media , Female , Gadolinium , Humans , Male , Middle Aged , Prospective Studies , ROC Curve , Sensitivity and SpecificityABSTRACT
A case report of a 40-year-old female with an unusually small pheochromocytoma of the organ of Zuckerkandl is discussed. The tumor is diagnosed by magnetic resonance imaging MRI examination, which was requested to evaluate her as a potential renal donor. There is a family history of Carney s triad gastric leiomyosarcoma, extra-adrenal pheochromocytoma and pulmonary chondroma. The MRI technique and findings are discussed.